Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis

Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance

(2016) Sophie H. van Olphen et al.   MEDICINE

hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett’s esophagus and can be exploited for a novel endoscopic surveillance

(2016) Elena Lastraioli et al.   Oncotarget

Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett's esophagus and epithelial changes indefinite for dysplasia

(2015) Bela Horvath et al.   Gastroenterology Report

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

(2013) Rebecca C Fitzgerald et al.   GUT

Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus

(2012) Elizabeth L. Bird–Lieberman et al.   GASTROENTEROLOGY

Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus

(2012) Florine Kastelein et al.   GUT

The Incidence of Esophageal Adenocarcinoma in Barrett's Esophagus Has Been Overestimated

(2011) Tusar K Desai et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Role of Acid Suppression in the Development and Progression of Dysplasia in Patients with Barrett’s Esophagus

(2011) F. Kastelein et al.   DIGESTIVE DISEASES

American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus

(2011) Stuart J. Spechler et al.   GASTROENTEROLOGY

Tobacco Smoking Increases the Risk of High-Grade Dysplasia and Cancer Among Patients With Barrett's Esophagus

(2011) Helen G. Coleman et al.   GASTROENTEROLOGY

The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis

(2011) Tusar K Desai et al.   GUT

Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study

(2011) S. Bhat et al.   JNCI-Journal of the National Cancer Institute

Incidence of Adenocarcinoma among Patients with Barrett's Esophagus

(2011) Frederik Hvid-Jensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low-Grade Dysplasia in Barrett's Esophagus: Overdiagnosed and Underestimated

(2010) Wouter L Curvers et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma

(2010) Sachin Wani et al.   Clinical Gastroenterology and Hepatology

Receipt of Previous Diagnoses and Endoscopy and Outcome From Esophageal Adenocarcinoma: A Population-Based Study With Temporal Trends

(2009) Gregory S Cooper et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Aneuploidy and Overexpression of Ki67 and p53 as Markers for Neoplastic Progression in Barrett's Esophagus: A Case–Control Study

(2009) Marjolein Sikkema et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis

(2009) Marjolein Sikkema et al.   Clinical Gastroenterology and Hepatology

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta-Analysis

(2008) Fouad Yousef et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus

(2008) Kenneth K. Wang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans

(2008) Joel H. Rubenstein et al.   GASTROINTESTINAL ENDOSCOPY